Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors

Clinical trial NCT04344795 · COMPLETED

Trial details

NCT number: NCT04344795
Sponsor: Tempest Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Colorectal Cancer Non Small Cell Lung Cancer Squamous Cell Carcinoma of Head and Neck Urothelial Carcinoma Endometrial Cancer Gastroesophageal Junction Adenocarcinoma Gastric Adenocarcinoma Solid Tumors With PIK3Ca Mutation

Start date: 2020-05-06
Primary completion: 2024-09-25
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.